Antibody-secreting B cells (plasma cells) were assessed by B cell ELISPOT assay according to the manufacture’s protocol (MabTech, Nacka Strand, Sweden). Briefly, ELISPOT plates were coated with capture anti-IgG or anti-IgM antibody (BD Pharmingen), and then spleen and bone marrow cell suspensions in 5% FBS/complete RPMI were added to each well and incubated for 24 h at 37°C in 5% CO2. Plates were extensively washed to remove the cells and biotinylated anti-IgG or anti-IgM antibody was added followed by Streptavidin-ALP and substrate (BCIP/NBT; MabTech). After color development, total spots per well were quantified using an ImmunoSpot Series 2 Analyzer (Cellular Technology Ltd., Shaker Heights, OH). Priming of donor-reactive T cells to IFN-γ–producing cells was quantified by ELISPOT assay as previously described (19 (link), 20 (link)).